The insights from SARS-CoV-2 antibodytreatment for future emerging infectious diseases

被引:1
|
作者
Wang, Yeming [1 ,2 ,3 ,4 ,5 ]
Cao, Bin [1 ,2 ,3 ,4 ,5 ]
机构
[1] Natl Ctr Resp Med, Beijing, Peoples R China
[2] State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China
[5] China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China
来源
LANCET INFECTIOUS DISEASES | 2024年 / 24卷 / 01期
关键词
D O I
10.1016/S1473-3099(23)00454-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:2 / 3
页数:2
相关论文
共 50 条
  • [21] Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
    Han, Pengcheng
    Su, Chao
    Zhang, Yanfang
    Bai, Chongzhi
    Zheng, Anqi
    Qiao, Chengpeng
    Wang, Qing
    Niu, Sheng
    Chen, Qian
    Zhang, Yuqin
    Li, Weiwei
    Liao, Hanyi
    Li, Jing
    Zhang, Zengyuan
    Cho, Heecheol
    Yang, Mengsu
    Rong, Xiaoyu
    Hu, Yu
    Huang, Niu
    Yan, Jinghua
    Wang, Qihui
    Zhao, Xin
    Gao, George Fu
    Qi, Jianxun
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [22] Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
    Pengcheng Han
    Chao Su
    Yanfang Zhang
    Chongzhi Bai
    Anqi Zheng
    Chengpeng Qiao
    Qing Wang
    Sheng Niu
    Qian Chen
    Yuqin Zhang
    Weiwei Li
    Hanyi Liao
    Jing Li
    Zengyuan Zhang
    Heecheol Cho
    Mengsu Yang
    Xiaoyu Rong
    Yu Hu
    Niu Huang
    Jinghua Yan
    Qihui Wang
    Xin Zhao
    George Fu Gao
    Jianxun Qi
    Nature Communications, 12
  • [23] An Infectious cDNA Clone of SARS-CoV-2
    Xie, Xuping
    Muruato, Antonio
    Lokugamage, Kumari G.
    Narayanan, Krishna
    Zhang, Xianwen
    Zou, Jing
    Liu, Jianying
    Schindewolf, Craig
    Bopp, Nathen E.
    Aguilar, Patricia, V
    Plante, Kenneth S.
    Weaver, Scott C.
    Makino, Shinji
    LeDuc, James W.
    Menachery, Vineet D.
    Shi, Pei-Yong
    CELL HOST & MICROBE, 2020, 27 (05) : 841 - +
  • [24] The Future of SARS-CoV-2 Vaccination
    Bachmann, Martin F.
    Mohsen, Mona O.
    Speiser, Daniel E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (09): : 899 - 899
  • [25] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [26] Emerging neurotropic features of SARS-CoV-2
    Zhan, Wen-Rong
    Huang, Jing
    Zeng, Peng-Ming
    Tian, Wei-Ya
    Luo, Zhen-Ge
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (10) : 705 - 711
  • [27] Emerging complexities of SARS-CoV-2 pandemic
    Gupta, Harish
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) : 3528 - 3529
  • [28] Emerging Dominant SARS-CoV-2 Variants
    Chen, Jiahui
    Wang, Rui
    Hozumi, Yuta
    Liu, Gengzhuo
    Qiu, Yuchi
    Wei, Xiaoqi
    Wei, Guo-Wei
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (01) : 335 - 342
  • [29] Genes of SARS-CoV-2 and emerging variants
    Dhakal, Sudip
    Macreadie, Ian
    MICROBIOLOGY AUSTRALIA, 2021, 42 (01) : 10 - 12
  • [30] SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases
    Ferreira, Gonzalo
    Santander, Axel
    Savio, Florencia
    Guirado, Mariana
    Sobrevia, Luis
    Nicolson, Garth L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (12):